GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Pretax Margin %

OKYO Pharma (LSE:OKYO) Pretax Margin % : % (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is OKYO Pharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OKYO Pharma's Pre-Tax Income for the six months ended in Mar. 2023 was £-6.75 Mil. OKYO Pharma's Revenue for the six months ended in Mar. 2023 was £0.00 Mil. Therefore, OKYO Pharma's pretax margin for the quarter that ended in Mar. 2023 was %.

The historical rank and industry rank for OKYO Pharma's Pretax Margin % or its related term are showing as below:


LSE:OKYO's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -152.6
* Ranked among companies with meaningful Pretax Margin % only.

OKYO Pharma Pretax Margin % Historical Data

The historical data trend for OKYO Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Pretax Margin % Chart

OKYO Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OKYO Pharma Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OKYO Pharma's Pretax Margin %

For the Biotechnology subindustry, OKYO Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OKYO Pharma's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Pretax Margin % falls into.



OKYO Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OKYO Pharma's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-10.946/0
= %

OKYO Pharma's Pretax Margin for the quarter that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-6.754/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OKYO Pharma  (LSE:OKYO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


OKYO Pharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of OKYO Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OKYO Pharma (LSE:OKYO) Business Description

Traded in Other Exchanges
Address
14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.